Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 544

Welcome to Firstlinks Edition 544 with weekend update

  •   25 January 2024
  • 6
  •      
  •   

The Weekend Edition includes a market update plus Morningstar adds links to two additional articles.

Most investors love to buy stocks that others own, when what they should be doing is looking at ones that others ignore.

For instance, many large fund managers can’t buy small or microcap stocks because they’re too illiquid. They’ll often stay away from stocks that have fallen dramatically in value because they’ll get too many hard questions from asset consultants. And they’ll shun stocks with serious ESG issues, such as oil and coal, because they either have ESG mandates or risk losing investors in their funds.

Investors can take advantage of these constraints on institutions to get an edge in markets. Here’s a look at three strategies that can deliver market-beating returns.

Dogs of the Dow/ASX

In his 1991 book ‘Beating the Dow’, Michael O’Higgins outlined a strategy of investing in underperforming companies which he dubbed ‘Dogs of the Dow’. The strategy involves buying the ten worst-performing stocks from the Dow Jones Industrial Average (DJIA) from the past 12 months at the beginning of the year, and then selling them at the end of December. O’Higgins added one caveat: the stocks selected should be restricted to only those paying dividends.

The rationale behind the strategy is that the ten worst performing stocks in a given year will have gone down so far in price that investors hate them. Anyone who could have sold them probably has, which can mean there are few sellers left. Fund managers won’t want to hold onto these stocks at the start of a new year because they won’t want to justify owning them to asset consultants and their investors. In effect, these managers can become forced sellers of the stocks. And because the stocks are so deeply out favour, they're often trading at cheap prices.

The reason for restricting the strategy to the DJIA is that large caps are more likely to have the financial strength to stay in business. Adding a further filter of investing only in dividend paying companies helps to ensure that the stocks have the financial health to pay out a dividend from their profits.

How has the strategy performed? Hugh Dive from Atlas Funds Management has tracked a 'Dogs of the ASX' strategy over the past decade. In 2023, the average equal-weighted return of Dogs from the previous year returned 26% versus the ASX 200’s gain of 12%.

The best performers included James Hardie and Reece, which were sold down in 2022 on concerns of a US recession, only to come storming back last year as the recession never eventuated. Other gainers were IT companies which were hammered in the broader tech selloff of 2022, before bouncing hard in 2023.

Since 2013, the Dogs of the ASX have beaten the ASX 200 in 7 out of 10 years. Overall, the cumulative outperformance of the Dogs has been impressive.


Source: Hugh Dive, Atlas Funds Management

Hugh Dive admits there are few fund managers who would be able to run this type of strategy. They wouldn’t be able to justify holding stocks with such bleak outlooks to asset consultants at the beginning of a year.

I would add another reason: it’s psychologically hard, even for a fund manager, to hold onto stocks that have tanked. It can be easier to put them in the too-hard basket and move on.

For the enterprising individual investor, though, that can provide potential opportunities.

Tobacco stocks

Morningstar’s Shani Jayamanne wrote a recent article on one of the best performing stocks of the past 100 years: Philip Morris. US$1,000 invested in the company in 1925 would be worth close to US$1 billion now. That’s an annual return of more than 15% over that period.

Philip Morris is a US-based tobacco company. It’s well known that tobacco has been a declining industry for decades. Smoking peaked in the US in 1961 and as its health issues became widely known, massive lawsuits against companies followed. Warning labels were slapped on products, governments restricted advertising of tobacco, and repeatedly raised taxes on companies.

The question is: how has Philip Morris performed so well on the stock market given these headwinds? One of the reasons is that investors have largely stayed away from the stock, particularly institutional investors. They haven't wanted to be part of the lawsuits, health warnings and bad press that have accompanied Philip Morris along the way. Not to mention the rise of ESG in the past 20 years and the restrictions that's placed on funds investing in ‘sin’ stocks.

Consequently, Philip Morris has traded at cheap levels for much of the period. A low share price does a couple things:

  • It raises the cost of capital for a company. The means that Philip Morris and other tobacco companies have had higher return hurdle rates when it comes to new projects. Put simply, it's restricted them from undertaking aggressive expansion. It's also reduced competition from new companies. That's limited industry supply and consolidated the power of existing players such as Philip Morris.
  • It allows a company to buy back shares at cheap prices. Philip Morris has regularly bought back shares over the decades, and that' paid off for investors.

Another contributor to the performance of Philip Morris and other tobacco stocks has been their ability to raise prices to cover increased taxes on their products. With declining tobacco volumes, increasing prices has been critical to boosting earnings for these companies over time.

US sector returns, 1900-2019

Source: Credit Suisse

Small/value stocks

Many institutions are restricted from buying small and microcap stocks for liquidity reasons. Small cap stocks don’t have enough turnover for these funds to establish meaningful positions.

It means there’s less investor demand for these stocks. Not only that, but there are likely to be few broker analysts covering the stocks. And limited media coverage of the stocks too. All of this increases the chances that these types of companies will be neglected and cheap.

A well-known fund manager, Dimensional Fund Advisors (DFA), was founded in 1981 to take advantage of these gaps in the market. The founders were largely influenced by the work of academics Eugene Fama (aka ‘The Father of Modern Finance’ or ‘The Father of the Efficient Market Hypothesis’) and his colleague Kenneth French, who developed a statistical model of asset prices, and observed that two classes of stocks tended to do better than the broader market: small caps, and stocks with high book-to-price ratios.

DFA took these observations and formed low-cost funds based on them. The success of the strategies has resulted in funds under management ballooning close to US$1 trillion.

DFA certainly aren’t the only firm to take advantage of small cap and value strategies to beat markets, though they're one of the largest and most well-known.

***

In my article this week, I look at the rout in battery metal prices and the lessons for investors.

James Gruber

Also in this week's edition...

The major Australian banks have had a nice run of late as markets start to factor in a soft landing for the economy. But Firetrail's Scott Olsson believes that the market is overlooking some earnings headwinds that are likely to put pressure on bank share prices this year.

In 2022, the Federal Government introduced star ratings for aged care homes with the aim of providing simple, reliable information about the quality of care.  Yet a new report suggests that instead of providing the transparency older people need to compare and choose an aged care home, the star ratings may actually lead them to choose a home that is delivering poor care. Rachel Lane reviews the report's findings.

Bitcoin has seemingly gone mainstream with approval for the first U.S. ETFs that can directly invest in the cryptocurrency. The question for investors is whether Bitcoin warrants a small allocation in their portfolios. Peter Lazaroff examines the pros and cons.

ASX REITs have been left for dead, some unfairly. Airlie Funds Management's Jack McNally sees Charter Hall Group (ASX:CHC) as a case in point. He says the company has a stellar track record and its 2024 profit guidance is conservative and likely represents trough earnings. Combine that with a large discount to asset value, and the stock appears great value.

With markets having gone gangbusters over the past six months, it's no surprise that the well-known Fear & Greed Index, used to gauge the current mood of the market, shows that it's now close to ‘extreme greed’ mode. Jonathan Daffron says investors are underpricing risk and it's time to get cautious.

Tony Dillon has been doing some light holiday reading by boning up on Albert Einstein's Relativity Theory. Rediscovering his 'inner physics geek', Tony sees several metaphorical parallels between the theory and the world of finance

Two extra articles from Morningstar for the weekend. Johannes Faul looks at whether Kogan's shares are still attractive after a recent price surge, while Nathan Zaia does likewise with Judo Capital after its bounce post results

Lastly, in this week's whitepaper, Magellan looks at global infrastructure investment and the positive prospects for utilities.

***

Weekend market update

On Friday in the US, a modest pullback halted the S&P 500’s five-session string of fresh closing highs, as the broad index gave back an early push higher to finish slightly in the red. Meanwhile, the Nasdaq 100 again lagged to settle 1.5% below its Wednesday lunchtime levels. Treasurys saw some softness at the short-end as two-year yields climbed higher by six basis points to 4.34%, while the long bond remained unchanged at 4.38%, WTI crude climbed above US$78 a barrel and gold stayed at US$2,018 an ounce.

From AAP Netdesk:

The local share market on Thursday extended its winning streak to a fifth day, hitting its highest close since the opening session of 2024. The benchmark S&P/ASX200 index finished up 36.2 points, or 0.48%, to a three-week high of 7,555.4. The broader All Ordinaries rose 37.1 points, or 0.48%, to 7,785.2.
Miners outperformed for the second day running.

Iron ore futures rallied after China's central bank announced it would cut the reserve ratio requirement - which is used to control the supply of money in the economy and influence interest rates - by 0.5 percentage points. BHP gained 1.5% and Rio Tinto lifted 2.8%. Fortescue Metals climbed 2% after the Andrew Forrest-led company reiterated production guidance for fiscal 2024.

Mineral Resources jumped 7.1 per cent after the lithium miner kept volume and cost guidance unchanged, saying all assets remain profitable despite subdued ore prices.

Domino's Pizza plunged 28.5% to a four-year low after the fast food chain withdrew its guidance for financial year 2024 amid a slump in sales in Asia and France.

Oil and gas giant Santos climbed 0.8% after announcing its troubled Barossa gas project would require an extra $200-$300 million in capital expenditure after it was delayed by a court trial brought on by traditional Tiwi owners.

ResMed soared 6.4% higher after the sleep apnoea device manufacturer beat analyst earnings expectations for the December quarter.

The big banks were mixed, with CBA up 0.1%, ANZ 0.3% and Westpac 0.6%, while NAB dropped 0.3%.

Curated by James Gruber and Leisa Bell

Latest updates

PDF version of Firstlinks Newsletter

ASX Listed Bond and Hybrid rate sheet from NAB/nabtrade

Monthly Bond and Hybrid updates from ASX

Listed Investment Company (LIC) Indicative NTA Report from Bell Potter

LIC Monthly Report from Morningstar

Plus updates and announcements on the Sponsor Noticeboard on our website

 

6 Comments
Max W
January 27, 2024

To qualify for the Dogs List a company must pay a dividend, so how did XRO make the list at the end of 2022? It has never paid a dividend.

Hugh Dive
January 29, 2024

Xero was on the list Max as it was in the ASX100 as of 31st December 2022. While not paying a dividend, the company was generating over $1B in revenue and there was no prospect of XRO being unable to raise debt or equity to finance their activities if it got into difficulty. Conversely, some smaller companies falling out of the ASX 200 often find their issues terminal as capital becomes difficult to source, this is why we look at the ASX 100 as is the closest representation to the blue chip Dow Jones Industrial Average.

James Smith
January 26, 2024

Dogs of the ASX mean very poorly run companies. Why would anyone make friendship with such a gathering.

Hugh Dive
January 29, 2024

Not necessarily poorly run companies, though it would be hard to make the case that SGR or DMP have shot the lights out over the past 12 month.

Though every year in January the Dogs list looks awful and hard to make a case to own any of them. However since I started doing this in 2010 every year there have been at least 3 names that have shot the lights out in the following 12 months. The exception to this was 2012, where only one stock Bluescope (+42%) beat the ASX 200 (15%).

Patrick O
January 26, 2024

Love the Dogs of the ASX. Makes a lot of sense. I reckon a further filter could be debt. Then you would avoid trouble from the likes of Star, that are over-geared.

James Gruber
January 29, 2024

Hi Patrick, debt as a filter makes some sense. If there's one thing that gets companies into trouble, it's debt, and if there's one thing that gets them into more trouble, it's debt also...

James

 

Leave a Comment:

banner

Most viewed in recent weeks

Vale Graham Hand

It’s with heavy hearts that we announce Firstlinks’ co-founder and former Managing Editor, Graham Hand, has died aged 66. Graham was a legendary figure in the finance industry and here are three tributes to him.

Australian stocks will crush housing over the next decade, one year on

Last year, I wrote an article suggesting returns from ASX stocks would trample those from housing over the next decade. One year later, this is an update on how that forecast is going and what's changed since.

Avoiding wealth transfer pitfalls

Australia is in the early throes of an intergenerational wealth transfer worth an estimated $3.5 trillion. Here's a case study highlighting some of the challenges with transferring wealth between generations.

Taxpayers betrayed by Future Fund debacle

The Future Fund's original purpose was to meet the unfunded liabilities of Commonwealth defined benefit schemes. These liabilities have ballooned to an estimated $290 billion and taxpayers continue to be treated like fools.

Australia’s shameful super gap

ASFA provides a key guide for how much you will need to live on in retirement. Unfortunately it has many deficiencies, and the averages don't tell the full story of the growing gender superannuation gap.

Looking beyond banks for dividend income

The Big Four banks have had an extraordinary run and it’s left income investors with a conundrum: to stick with them even though they now offer relatively low dividend yields and limited growth prospects or to look elsewhere.

Latest Updates

Investment strategies

9 lessons from 2024

Key lessons include expensive stocks can always get more expensive, Bitcoin is our tulip mania, follow the smart money, the young are coming with pitchforks on housing, and the importance of staying invested.

Investment strategies

Time to announce the X-factor for 2024

What is the X-factor - the largely unexpected influence that wasn’t thought about when the year began but came from left field to have powerful effects on investment returns - for 2024? It's time to select the winner.

Shares

Australian shares struggle as 2020s reach halfway point

It’s halfway through the 2020s decade and time to get a scorecheck on the Australian stock market. The picture isn't pretty as Aussie shares are having a below-average decade so far, though history shows that all is not lost.

Shares

Is FOMO overruling investment basics?

Four years ago, we introduced our 'bubbles' chart to show how the market had become concentrated in one type of stock and one view of the future. This looks at what, if anything, has changed, and what it means for investors.

Shares

Is Medibank Private a bargain?

Regulatory tensions have weighed on Medibank's share price though it's unlikely that the government will step in and prop up private hospitals. This creates an opportunity to invest in Australia’s largest health insurer.

Shares

Negative correlations, positive allocations

A nascent theme today is that the inverse correlation between bonds and stocks has returned as inflation and economic growth moderate. This broadens the potential for risk-adjusted returns in multi-asset portfolios.

Retirement

The secret to a good retirement

An Australian anthropologist studying Japanese seniors has come to a counter-intuitive conclusion to what makes for a great retirement: she suggests the seeds may be found in how we approach our working years.

Sponsors

Alliances

© 2024 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.